Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon

Price transparency rattling hospitals to varying degrees, effects

A month and a half after hospitals were mandated to show their prices for shoppable services, anecdotal evidence shows some may be deeming the penalty of up to $300 per day insufficiently incentivizing.

Philips partnering with Saudi Arabia on national healthcare AI

The government of Saudi Arabia is bringing in Royal Philips to help the country of 35 million become a global leader in healthcare AI.

Thumbnail

6 steps major new coalition will pursue to grow Obamacare, reach for universal healthcare

A new alliance of powerful associations representing providers, payers, hospitals and employers has formed to push U.S. healthcare toward universal coverage.

The 10 most expensive drugs patients may give themselves

At a list price of $86,000 per month, Zokinvy is right now the costliest medication in the U.S. that patients can self-administer.

Vaccine distribution help on the way from Google

Google Cloud has launched an AI-backed technology toolkit to help government health personnel direct COVID vaccine doses and other resources where they’re most needed.

Proactive AI-based ICU patient monitoring cleared for market

The FDA has OK’d AI software that can predict worsening condition in ICU patients up to eight hours before the falloff produces symptoms.

Thumbnail

US drug prices soar above international averages

Drug prices in the U.S. are significantly higher than those in peer countries, according to new research from RAND. In fact, compared with 32 other countries combined, drug prices in the U.S. are 256% higher.

Thumbnail

AI poised to ‘speed up the overall revenue cycle’ for hospitals set back fiscally by COVID

Hospital leaders discouraged by COVID-19’s devastating toll on human life and wellbeing must also mind the price the crisis is exacting on their organization’s financial health.  

Displaying 1761 - 1768 of 6647

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup